Answers are grounded in this paper and cite their sources.
WHAT IS KNOWN AND OBJECTIVE: A variety of medication classes are available for diabetes; however, treatment options become limited due to adverse effect profiles and cost. Current diabetes guidelines include agents not originally developed for diabetes treatment, bromocriptine and colesevelam. COMMENT: Other non-diabetes medications demonstrating haemoglobin A1c lowering, including agents for weight loss, depression, anaemia and coronary artery disease, are described in this review article. WHAT IS NEW AND CONCLUSION: More research looking into the impact of non-diabetes medications on blood glucose may offer additional diabetes treatment strategies.
No takes yet. Share an insight, caveat, or question.
Tillman et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: